Mr. David Danziger reports

AUMENTO CAPITAL V CORPORATION: COMPLETION OF SPECIAL MEETING OF SHAREHOLDERS

All of the resolutions considered at Aumento Capital V Corp.'s special meeting of shareholders were approved today by shareholders of the corporation.

Among other things, the shareholders approved a resolution to set the number of directors of corporation at six, an increase from the current number of three, and the appointment of Josh Arbuckle, Ryan Hunter and Graeme Norwood as the additional directors of the corporation, each of whom immediately resigned following shareholders meeting. The expansion of the board was done to accommodate the appointment of a board of six members who are anticipated to be appointed upon completion of the closing of the corporation's previously announced qualifying transaction with WeedMD RX Inc.

The current board comprises Roger Daher, David Danziger and Paul Pathak, who will all remain on the board until completion of the transaction.

About WeedMD RX

WeedMD is a licensed producer of medical cannabis pursuant to the access to cannabis for medical purposes regulations (ACMPR). WeedMD operates a 25,000-square-foot, scalable production facility in Aylmer, Ont., with four acres of property for future expansion. The company is focused on providing consistent, quality medicine to the long-term care and assisted living markets in Canada through its comprehensive platform developed exclusively for that industry. WeedMD is dedicated to educating health care practitioners and furthering public understanding of the role medical cannabis can play as a viable alternative to prescription medication in relieving a variety of chronic medical conditions and illnesses.

Aumento will issue additional press releases related to the final legal structure of the transaction, officers and directors of the resulting issuer, sponsorship, and other material information as it becomes available.

We seek Safe Harbor.